Drug intelligence / Profile preview

carnosic acid

Development stage
Preclinical
Modality
Nucleic Acid-Directed Small Molecules → Small Molecules, Covalent Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules
Administration
Oral
01

Overview

Carnosic acid is a naturally occurring abietane diterpenoid compound found primarily in rosemary (Rosmarinus officinalis) and sage (Salvia officinalis). It acts as a potent antioxidant, anti-inflammatory, and neuroprotective agent. Mechanistically, carnosic acid activates the KEAP1/NRF2 transcriptional pathway, leading to the induction of phase 2 detoxifying enzymes and cytoprotective proteins that combat oxidative stress and inflammation. It also inhibits the NLRP3 inflammasome, contributing to its anti-inflammatory effects. Carnosic acid has demonstrated potential benefits in preclinical models for neurodegenerative diseases such as Alzheimer's disease and Parkinson's disease by preventing amyloid-beta-induced neurodegeneration, inducing autophagy, reducing pro-inflammatory cytokines via Nuclear factor kappa B (NF-kB) pathway inhibition, promoting synaptic health, and alleviating metabolic syndrome features in animal studies. The compound is generally regarded as safe (GRAS) by the FDA but is not an approved pharmaceutical drug; it is used mainly as a food preservative or dietary supplement ingredient[1][4][5][6].

Other names
carnosic acidSalvin
02

Targets

KEAP1 (Kelch-like ECH-associated protein 1)

Beyond the preview

Go deeper on carnosic acid.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on carnosic acid.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call